ZFP2 Inhibitors
Chemicals classified as indirect ZFP2 inhibitors encompass a broad spectrum of compounds that can affect the protein's ability to exert its function within the cell. By targeting different aspects of the cellular environment, these compounds can alter the transcriptional regulation and signaling pathways associated with ZFP2. Zinc chelators, for example, can deprive ZFP2 of the essential zinc ions required for its structural integrity and DNA-binding ability. Similarly, compounds that modify DNA structure or the epigenetic landscape also have the capacity to affect the interactions between ZFP2 and its target genes, thereby influencing gene expression profiles. In addition, transcriptional inhibitors can suppress the expression of various genes, including those that are potentially regulated by ZFP2.
Moreover, the indirect inhibition of ZFP2 involves not only the modulation of gene expression but also the perturbation of cellular signaling pathways that can have downstream effects on ZFP2's role. For instance, inhibitors of signaling kinases can disrupt pathways that ultimately lead to changes in the transcriptional activity where ZFP2 is implicated. Proteasome inhibitors and compounds that interfere with protein-protein interactions can also impact the stability and functional interactions of ZFP2 within the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TPEN | 16858-02-9 | sc-200131 | 100 mg | $130.00 | 10 | |
A zinc chelator that can sequester Zn2+ ions, potentially disrupting the zinc finger domains of ZFP2 and impairing its ability to bind DNA. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms DNA adducts and may prevent the binding of ZFP2 to its target DNA sequences by altering the DNA structure. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Interferes with DNA and RNA polymerase activities, which can disrupt the transcriptional programs associated with ZFP2. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase the cellular levels of proteins, affecting proteins that interact with ZFP2 and its regulatory pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that alters DNA methylation patterns, affecting gene expression and the regulatory roles of ZFP2. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that changes chromatin structure and gene expression profiles, which may affect ZFP2-mediated transcriptional regulation. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
Disrupts the interaction between CBP/p300 and transcription factors, potentially altering the transcriptional activity where ZFP2 is involved. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A transcriptional inhibitor that can suppress the expression of a wide range of genes, including those regulated by ZFP2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of the MAPK/ERK pathway, which can affect cellular signaling and gene expression related to ZFP2's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter intracellular signaling pathways and impact gene regulation where ZFP2 might play a role. | ||||||